Lipidic Profile Stabilization refers to the therapeutic management of circulating lipid components to achieve optimal levels of atherogenic and protective particles, thereby reducing cardiovascular risk. This stabilization involves achieving target concentrations for specific lipoproteins, often emphasizing the reduction of small, dense LDL particles and optimization of HDL function. It is a critical component of preventative endocrinology and cardiometabolic care.
Origin
The term evolved from early lipidology, which focused narrowly on total cholesterol, toward modern understanding emphasizing lipoprotein particle number and structure. ‘Stabilization’ implies achieving a sustained, healthy equilibrium rather than transient correction.
Mechanism
Stabilization is achieved through modulating hepatic lipoprotein synthesis, enhancing peripheral lipoprotein receptor activity, or influencing intestinal lipid absorption. Dietary modifications, targeted nutraceuticals, or pharmacologic agents work to normalize the balance between pro-atherogenic species, like VLDL remnants, and protective particles. Maintaining stability is key to preventing plaque progression.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.